MedTrace Logo

BI 671800 ED in Steroid-naive Asthmatic Patients

NCT01092143 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 389

Last updated 2022-05-31

Study results available
· View outcomes & findings →

Summary

This is a 6 week study to investigate the effectiveness and safety of BI 671800 ED in patients with asthma who do not take inhaled corticosteroids.

Conditions

Interventions

DRUG

BI 671800

BI 671800

DRUG

Fluticasone propionate placebo

Placebo matching Fluticasone propionate

DRUG

Fluticasone propionate

Fluticasone propionate

DRUG

BI 671800 Placebo

Placebo matching BI 671800

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-18
Primary Completion
2011-03-26
Completion
2011-03-26

Countries

  • United States
  • Australia
  • Canada
  • Colombia
  • Mexico
  • New Zealand
  • Peru
  • Philippines
  • South Korea
  • Taiwan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01092143 on ClinicalTrials.gov